Elevance Health, Inc.
ELV
$336.36
-$3.04-0.90%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.93% | 9.66% | 4.81% | 1.06% | 1.45% |
| Total Other Revenue | 12.09% | 13.02% | 16.31% | 14.75% | 12.92% |
| Total Revenue | 11.96% | 10.21% | 6.63% | 3.19% | 3.20% |
| Cost of Revenue | 14.56% | 12.52% | 6.64% | 2.60% | 1.79% |
| Gross Profit | 5.24% | 4.37% | 6.58% | 4.75% | 7.00% |
| SG&A Expenses | 13.56% | 9.72% | 10.84% | 7.82% | 3.55% |
| Depreciation & Amortization | 4.38% | -14.57% | -19.19% | -34.46% | -32.57% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.29% | 11.75% | 7.47% | 3.57% | 1.99% |
| Operating Income | -22.65% | -13.35% | -6.76% | -2.97% | 25.11% |
| Income Before Tax | -14.44% | -17.62% | -3.40% | 2.45% | 6.96% |
| Income Tax Expenses | -17.64% | -9.48% | 3.17% | 12.12% | 10.92% |
| Earnings from Continuing Operations | -13.48% | -19.94% | -5.29% | -0.33% | 5.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -82.76% | 10.00% | 37.50% | 325.00% | 170.73% |
| Net Income | -13.79% | -19.89% | -5.24% | -0.12% | 7.04% |
| EBIT | -22.65% | -13.35% | -6.76% | -2.97% | 25.11% |
| EBITDA | -19.11% | -11.97% | -7.35% | -5.55% | 17.32% |
| EPS Basic | -11.07% | -17.77% | -3.21% | 1.71% | 9.10% |
| Normalized Basic EPS | -25.87% | -15.45% | -7.94% | -3.11% | 31.06% |
| EPS Diluted | -10.83% | -17.61% | -3.14% | 1.74% | 9.17% |
| Normalized Diluted EPS | -25.73% | -15.37% | -7.94% | -3.13% | 31.23% |
| Average Basic Shares Outstanding | -2.85% | -2.29% | -2.00% | -1.84% | -1.90% |
| Average Diluted Shares Outstanding | -3.06% | -2.42% | -2.07% | -1.90% | -1.96% |
| Dividend Per Share | 6.12% | 7.40% | 8.73% | 10.14% | 11.36% |
| Payout Ratio | 0.19% | 0.31% | 0.12% | 0.08% | 0.02% |